Daiwa Securities Group Inc. Buys 700 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Daiwa Securities Group Inc. boosted its stake in shares of DocuSign, Inc. (NASDAQ:DOCUFree Report) by 4.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,372 shares of the company’s stock after purchasing an additional 700 shares during the quarter. Daiwa Securities Group Inc.’s holdings in DocuSign were worth $876,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in the stock. Doheny Asset Management CA bought a new stake in DocuSign during the second quarter valued at about $410,000. Andra AP fonden boosted its position in DocuSign by 9.0% during the second quarter. Andra AP fonden now owns 424,100 shares of the company’s stock valued at $22,689,000 after purchasing an additional 34,900 shares in the last quarter. Choreo LLC bought a new stake in DocuSign during the second quarter valued at about $242,000. Quest Partners LLC raised its stake in DocuSign by 1,011.1% in the second quarter. Quest Partners LLC now owns 10,555 shares of the company’s stock valued at $565,000 after buying an additional 9,605 shares during the last quarter. Finally, Acadian Asset Management LLC raised its stake in DocuSign by 141.7% in the second quarter. Acadian Asset Management LLC now owns 526,195 shares of the company’s stock valued at $28,143,000 after buying an additional 308,493 shares during the last quarter. Institutional investors own 77.64% of the company’s stock.

DocuSign Trading Up 0.2 %

Shares of DOCU stock opened at $56.63 on Monday. The stock has a 50 day moving average of $55.57 and a 200 day moving average of $56.09. The stock has a market cap of $11.59 billion, a P/E ratio of 108.90, a P/E/G ratio of 5.99 and a beta of 0.93. DocuSign, Inc. has a twelve month low of $38.11 and a twelve month high of $64.76.

DocuSign (NASDAQ:DOCUGet Free Report) last announced its quarterly earnings results on Thursday, September 5th. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.17. DocuSign had a return on equity of 16.18% and a net margin of 34.56%. The company had revenue of $736.03 million during the quarter, compared to analysts’ expectations of $727.20 million. During the same period last year, the business earned $0.09 earnings per share. DocuSign’s quarterly revenue was up 7.0% on a year-over-year basis. On average, research analysts predict that DocuSign, Inc. will post 0.99 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Needham & Company LLC reiterated a “hold” rating on shares of DocuSign in a research note on Friday, September 6th. Morgan Stanley decreased their price target on DocuSign from $65.00 to $62.00 and set an “equal weight” rating for the company in a research note on Friday, June 7th. Robert W. Baird increased their price target on DocuSign from $55.00 to $59.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. JMP Securities reiterated a “market outperform” rating and issued a $84.00 price target on shares of DocuSign in a research note on Thursday, September 5th. Finally, Piper Sandler decreased their price target on DocuSign from $65.00 to $60.00 and set a “neutral” rating for the company in a research note on Friday, June 7th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, DocuSign has an average rating of “Hold” and an average target price of $61.45.

Get Our Latest Stock Report on DocuSign

Insider Buying and Selling at DocuSign

In other DocuSign news, CEO Allan C. Thygesen sold 7,725 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $54.89, for a total value of $424,025.25. Following the sale, the chief executive officer now directly owns 109,918 shares of the company’s stock, valued at $6,033,399.02. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, Director Daniel D. Springer sold 70,983 shares of DocuSign stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $49.84, for a total value of $3,537,792.72. Following the sale, the director now directly owns 891,373 shares of the company’s stock, valued at $44,426,030.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Allan C. Thygesen sold 7,725 shares of DocuSign stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $54.89, for a total value of $424,025.25. Following the completion of the sale, the chief executive officer now directly owns 109,918 shares in the company, valued at $6,033,399.02. The disclosure for this sale can be found here. Over the last three months, insiders have sold 480,618 shares of company stock valued at $25,432,336. Company insiders own 1.66% of the company’s stock.

DocuSign Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Read More

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.